Skip to main content

RxHighlights

A monthly overview of treatment guidelines, important literature and key issues influencing today’s pharmacy and health care environment.

February 2026

Core topics in this month’s edition include:

  • Prezcobix® and Prezcobix PED (darunavir/cobicistat) – Expanded indication, new formulation
  • Avopef™ (etoposide) – New drug approval
  • Dupixent® (dupilumab) – New indication

Download